We will be accepting DPhil student applications to start in October 2021 soon.
Professor of Experimental Radiotherapeutics
- Group Leader, Oxford Institute for Radiation Oncology
- Honorary Consultant in Clinical Oncology, Oxford University Hospitals NHS Trust
Our research focus is on understanding and exploiting the biological effects of external beam ionizing radiation and therapeutic radionuclides in solid tumours (breast, lung, pancreas, oesophageal and colorectal cancers among others).
Katherine undertook specialist training in Clinical Oncology at the Hammersmith Hospital and doctoral research at Edinburgh University. In 1995 she was appointed as Staff Radiation Oncologist at the Princess Margaret Hospital and Scientist at the Ontario Cancer Institute, Toronto. She returned to the UK in 2006 to join the Oxford Institute for Radiation Oncology and established the Experimental Radiotherapeutics Group.
Sarah Able, Laboratory Manager
Ole Tietz, Postdoctoral Researcher
Fernando Cortezon-Tamarit, Postdoctoral Researcher
Joao Lourenco, DPhil Student
Anis Theljani, Postdoctoral Researcher
Rachel Anderson, DPhil Student
Abirami Lakshminarayanan, Postdoctoral Researcher
Sreejesh Sreedharan, Postdoctoral Researcher
Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer
Browning R. et al, (2021), Journal of Controlled Release
Orally administered oxygen nanobubbles enhance tumor response to sonodynamic therapy
Owen J. et al, (2021), Nano Select
Interactive Contouring Through Contextual Deep Learning
Trimpl M. et al, (2021), Medical Physics
Stereotactic Inverse Dose Planning After Yttrium-90 Selective Internal Radiation Therapy in Hepatocellular Cancer
Abbott E. et al, (2021), Advances in Radiation Oncology, 6
Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy
Tiwari R. et al, (2021), Chemical Science, 12, 2667 - 2673